annual D&A:
$37.77M+$4.89M(+14.88%)Summary
- As of today (July 1, 2025), CPRX annual depreciation & amortization is $37.77 million, with the most recent change of +$4.89 million (+14.88%) on December 31, 2024.
- During the last 3 years, CPRX annual D&A has risen by +$37.58 million (+19573.96%).
- CPRX annual D&A is now at all-time high.
Performance
CPRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$9.46M+$2000.00(+0.02%)Summary
- As of today (July 1, 2025), CPRX quarterly depreciation & amortization is $9.46 million, with the most recent change of +$2000.00 (+0.02%) on March 31, 2025.
- Over the past year, CPRX quarterly D&A has increased by +$30.00 thousand (+0.32%).
- CPRX quarterly D&A is now at all-time high.
Performance
CPRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$37.80M+$30.00K(+0.08%)Summary
- As of today (July 1, 2025), CPRX TTM depreciation & amortization is $37.80 million, with the most recent change of +$30.00 thousand (+0.08%) on March 31, 2025.
- Over the past year, CPRX TTM D&A has increased by +$2.09 million (+5.86%).
- CPRX TTM D&A is now at all-time high.
Performance
CPRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CPRX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.9% | +0.3% | +5.9% |
| 3 y3 years | +10000.0% | +10000.0% | +10000.0% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
CPRX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | +6283.0% | at high | >+9999.0% |
CPRX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $9.46M(+0.0%) | $37.80M(+0.1%) |
| Dec 2024 | $37.77M(+14.9%) | $9.46M(+0.1%) | $37.77M(+0.8%) |
| Sep 2024 | - | $9.45M(+0.2%) | $37.46M(+2.4%) |
| Jun 2024 | - | $9.44M(+0.1%) | $36.58M(+2.4%) |
| Mar 2024 | - | $9.43M(+3.1%) | $35.71M(+8.6%) |
| Dec 2023 | $32.88M(+2553.8%) | $9.14M(+6.7%) | $32.88M(+35.0%) |
| Sep 2023 | - | $8.57M(-0.0%) | $24.35M(+49.1%) |
| Jun 2023 | - | $8.57M(+29.8%) | $16.34M(+109.3%) |
| Mar 2023 | - | $6.60M(+973.2%) | $7.80M(+529.9%) |
| Dec 2022 | $1.24M(+545.3%) | $615.00K(+11.2%) | $1.24M(+88.6%) |
| Sep 2022 | - | $553.00K(+1394.6%) | $657.00K(+386.7%) |
| Jun 2022 | - | $37.00K(+8.8%) | $135.00K(+4.7%) |
| Mar 2022 | - | $34.00K(+3.0%) | $129.00K(-32.8%) |
| Dec 2021 | $192.00K(+108.7%) | $33.00K(+6.5%) | $192.00K(+7.9%) |
| Sep 2021 | - | $31.00K(0.0%) | $178.00K(+0.6%) |
| Jun 2021 | - | $31.00K(-68.0%) | $177.00K(+58.0%) |
| Mar 2021 | - | $97.00K(+410.5%) | $112.00K(+21.7%) |
| Dec 2020 | $92.00K(+67.3%) | $19.00K(-36.7%) | $92.00K(-215.0%) |
| Sep 2020 | - | $30.00K(-188.2%) | -$80.00K(+89.6%) |
| Jun 2020 | - | -$34.00K(-144.2%) | -$42.20K(-171.9%) |
| Mar 2020 | - | $77.00K(-150.3%) | $58.70K(+6.5%) |
| Dec 2019 | $55.00K(+44.7%) | -$153.00K(-325.7%) | $55.10K(-75.0%) |
| Sep 2019 | - | $67.80K(+1.3%) | $220.60K(+36.1%) |
| Jun 2019 | - | $66.90K(-8.9%) | $162.10K(+56.8%) |
| Mar 2019 | - | $73.40K(+487.2%) | $103.40K(+172.1%) |
| Dec 2018 | $38.00K(-16.8%) | $12.50K(+34.4%) | $38.00K(+17.3%) |
| Sep 2018 | - | $9300.00(+13.4%) | $32.40K(-9.7%) |
| Jun 2018 | - | $8200.00(+2.5%) | $35.90K(-11.8%) |
| Mar 2018 | - | $8000.00(+15.9%) | $40.70K(-10.9%) |
| Dec 2017 | $45.70K(+5.3%) | $6900.00(-46.1%) | $45.70K(-10.0%) |
| Sep 2017 | - | $12.80K(-1.5%) | $50.80K(+6.9%) |
| Jun 2017 | - | $13.00K(0.0%) | $47.50K(+9.7%) |
| Mar 2017 | - | $13.00K(+8.3%) | $43.30K(-0.5%) |
| Dec 2016 | $43.40K(+25.8%) | $12.00K(+26.3%) | $43.50K(+15.7%) |
| Sep 2016 | - | $9500.00(+8.0%) | $37.60K(-4.6%) |
| Jun 2016 | - | $8800.00(-33.3%) | $39.40K(-0.5%) |
| Mar 2016 | - | $13.20K(+116.4%) | $39.60K(+14.8%) |
| Dec 2015 | $34.50K | $6100.00(-46.0%) | $34.50K(-5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $11.30K(+25.6%) | $36.40K(+12.7%) |
| Jun 2015 | - | $9000.00(+11.1%) | $32.30K(+9.9%) |
| Mar 2015 | - | $8100.00(+1.3%) | $29.40K(+10.5%) |
| Dec 2014 | $26.60K(+18.2%) | $8000.00(+11.1%) | $26.60K(+9.5%) |
| Sep 2014 | - | $7200.00(+18.0%) | $24.30K(+6.6%) |
| Jun 2014 | - | $6100.00(+15.1%) | $22.80K(+1.8%) |
| Mar 2014 | - | $5300.00(-7.0%) | $22.40K(-0.4%) |
| Dec 2013 | $22.50K(+106.4%) | $5700.00(0.0%) | $22.50K(+15.4%) |
| Sep 2013 | - | $5700.00(0.0%) | $19.50K(+18.2%) |
| Jun 2013 | - | $5700.00(+5.6%) | $16.50K(+22.2%) |
| Mar 2013 | - | $5400.00(+100.0%) | $13.50K(+23.9%) |
| Dec 2012 | $10.90K(-74.5%) | $2700.00(0.0%) | $10.90K(-32.3%) |
| Sep 2012 | - | $2700.00(0.0%) | $16.10K(-23.0%) |
| Jun 2012 | - | $2700.00(-3.6%) | $20.90K(-46.7%) |
| Mar 2012 | - | $2800.00(-64.6%) | $39.20K(-8.4%) |
| Dec 2011 | $42.80K(+66.5%) | $7900.00(+5.3%) | $42.80K(+3.6%) |
| Sep 2011 | - | $7500.00(-64.3%) | $41.30K(+3.3%) |
| Jun 2011 | - | $21.00K(+228.1%) | $40.00K(+58.1%) |
| Mar 2011 | - | $6400.00(0.0%) | $25.30K(-1.6%) |
| Dec 2010 | $25.70K(-14.9%) | $6400.00(+3.2%) | $25.70K(-2.7%) |
| Sep 2010 | - | $6200.00(-1.6%) | $26.40K(-4.0%) |
| Jun 2010 | - | $6300.00(-7.4%) | $27.50K(-5.2%) |
| Mar 2010 | - | $6800.00(-4.2%) | $29.00K(-4.0%) |
| Dec 2009 | $30.20K(-7.9%) | $7100.00(-2.7%) | $30.20K(-3.5%) |
| Sep 2009 | - | $7300.00(-6.4%) | $31.30K(-2.8%) |
| Jun 2009 | - | $7800.00(-2.5%) | $32.20K(-1.2%) |
| Mar 2009 | - | $8000.00(-2.4%) | $32.60K(-0.6%) |
| Dec 2008 | $32.80K(+107.6%) | $8200.00(0.0%) | $32.80K(+1.5%) |
| Sep 2008 | - | $8200.00(0.0%) | $32.30K(+17.5%) |
| Jun 2008 | - | $8200.00(0.0%) | $27.50K(+25.6%) |
| Mar 2008 | - | $8200.00(+6.5%) | $21.90K(+38.6%) |
| Dec 2007 | $15.80K(+222.4%) | $7700.00(+126.5%) | $15.80K(+95.1%) |
| Sep 2007 | - | $3400.00(+30.8%) | $8100.00(+72.3%) |
| Jun 2007 | - | $2600.00(+23.8%) | $4700.00(+123.8%) |
| Mar 2007 | - | $2100.00 | $2100.00 |
| Dec 2006 | $4900.00(+250.0%) | - | - |
| Dec 2005 | $1400.00(+250.0%) | - | - |
| Dec 2004 | $400.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual D&A year-on-year change?
- What is Catalyst Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly D&A year-on-year change?
- What is Catalyst Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM D&A year-on-year change?
What is Catalyst Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CPRX is $37.77M
What is the all time high annual D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual depreciation & amortization is $37.77M
What is Catalyst Pharmaceuticals annual D&A year-on-year change?
Over the past year, CPRX annual depreciation & amortization has changed by +$4.89M (+14.88%)
What is Catalyst Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CPRX is $9.46M
What is the all time high quarterly D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly depreciation & amortization is $9.46M
What is Catalyst Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CPRX quarterly depreciation & amortization has changed by +$30.00K (+0.32%)
What is Catalyst Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CPRX is $37.80M
What is the all time high TTM D&A for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM depreciation & amortization is $37.80M
What is Catalyst Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CPRX TTM depreciation & amortization has changed by +$2.09M (+5.86%)